the company
Phares Drug Delivery AG: an innovation-based service provider focused on the formulation and profiling of poorly soluble pharmaceutical compounds. Phares delivers the right level of service for each stage of pharmaceutical development. Solubilization and bioavailability improvement are key goals of the formulation techniques. Phares has expertise in oral, parenteral and topical delivery. Phares was founded in 1985 and is privately owned.
Our skills: Phares’ formulators are experienced industrial pharmacists with decades of cumulative experience working on insoluble compounds. This skill translates into an expert understanding of the real requirements of preclinical and clinical development, as well as cGMP and the importance of regulatory acceptability of excipients and manufacturing processes.
Tailored programs: Our staged programs are individually tailored according to your needs and the requirements for the development stage of your compound. Clients retain full ownership of intellectual property of their API, and API-related formulation patents belong solely to the client. Clients also retain full control over manufacturing.
Where we are: Our state of the art facilities are located on the outskirts of Basel, Switzerland on the Rhine river and just across the border from France and Germany
BioPharm America
Atlanta, Georgia
September 9-10, 2008
AAPS
Atlanta, Georgia
November 16-20, 2008
BIO-Europe
Mannheim/Heidelberg, Germany
November 17-19, 2008
© 2006 Phares Drug Delivery AG